Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 02-2012 | 11-2011 | 08-2011 | 05-2011 | 02-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,205 | 5,391 | 1,953 | N/A | 6,908 |
| Depreciation Amortization | 4,111 | 2,729 | 1,355 | N/A | 3,910 |
| Income taxes - deferred | 157 | -463 | -299 | N/A | 1,237 |
| Accounts receivable | -1,643 | -7,268 | 1,333 | N/A | -111 |
| Accounts payable and accrued liabilities | -2,378 | 2,172 | 1,484 | N/A | 442 |
| Other Working Capital | 2,985 | -4,732 | 2,440 | N/A | 1,598 |
| Other Operating Activity | -4,902 | 1,429 | -3,908 | 0 | -1,550 |
| Operating Cash Flow | $8,535 | $-742 | $4,358 | $N/A | $12,434 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,030 | 3,888 | -3,988 | N/A | -11,335 |
| PPE Investments | -3,892 | -3,042 | -1,561 | N/A | -4,875 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -15,000 |
| Investing Cash Flow | $-862 | $846 | $-5,549 | $N/A | $-31,210 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -3,330 | -2,330 | -1,000 | N/A | -2,940 |
| Common Stock Issued | 91 | 91 | 0 | N/A | 126 |
| Common Stock Repurchased | -5,007 | -4,805 | N/A | N/A | -1,184 |
| Other Financing Activity | 4,972 | 3,040 | 1,298 | 0 | 1,636 |
| Financing Cash Flow | $-3,274 | $-4,004 | $298 | $N/A | $-2,362 |
| Beginning Cash Position | 8,135 | 8,135 | 8,135 | N/A | 27,817 |
| End Cash Position | 12,534 | 4,235 | 7,242 | N/A | 6,679 |
| Net Cash Flow | $4,399 | $-3,900 | $-893 | $N/A | $-21,138 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,535 | -742 | 4,358 | N/A | 12,434 |
| Capital Expenditure | -3,892 | -3,042 | -1,561 | N/A | -4,875 |
| Free Cash Flow | 4,643 | -3,784 | 2,797 | 0 | 7,559 |